Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?

被引：79

作者：

Bodier-Montagutelli, Elsa ^{[1
,2
,3
]}

Mayor, Alexie ^{[1
,2
,4
]}

Vecellio, Laurent ^{[1
,2
]}

Respaud, Renaud ^{[1
,2
,3
]}

Heuze-Vourc'h, Nathalie ^{[1
,2
]}

机构：

[1] Univ Tours, Ctr Etud Pathol Resp, Tours, France

[2] Ctr Etud Pathol Resp, INSERM, U1100, Tours, France

[3] CHRU Tours, Serv Pharm, Tours, France

[4] Sanofi Aventis Rech Dev, Formulat Dev Unit Biotherapeut, Vitry Sur Seine, France

来源：

EXPERT OPINION ON DRUG DELIVERY | 2018年 / 15卷 / 08期

关键词：

Inhalation; protein therapeutics; formulation; nebulizers; aerosol therapy; INHALATION-THERAPY; BIOTHERAPEUTICS; FORMULATIONS; PERFORMANCE; ANTIBODY; DISEASES;

D O I：

10.1080/17425247.2018.1503251

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

引用

页码：729 / 736

页数：8

共 15 条

[1]

The function and performance of aqueous aerosol devices for inhalation therapy [J].

Carvalho, Thiago C. ;

McConville, Jason T. .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2016, 68 (05) :556-578

[2]

Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn) [J].

Dall'Acqua, William F. ;

Kiener, Peter A. ;

Wu, Herren .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (33) :23514-23524

[3]

Dry powder inhalation: past, present and future [J].

de Boer, A. H. ;

Hagedoorn, P. ;

Hoppentocht, M. ;

Buttini, F. ;

Grasmeijer, F. ;

Frijlink, H. W. .

EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (04) :499-512

[4]

Advances in pulmonary therapy and drug development: Lung tissue engineering to lung-on-a-chip [J].

Doryab, Ali ;

Amoabediny, Ghassem ;

Salehi-Najafabadi, Amir .

BIOTECHNOLOGY ADVANCES, 2016, 34 (05) :588-596

[5]

Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice [J].

Filipe, Vasco ;

Jiskoot, Wim ;

Basmeleh, Abdul Hafid ;

Halim, Andhyk ;

Schellekens, Huub ;

Brinks, Vera .

MABS, 2012, 4 (06) :740-752

[6]

Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system [J].

Guilleminault, L. ;

Azzopardi, N. ;

Arnoult, C. ;

Sobilo, J. ;

Herve, V. ;

Montharu, J. ;

Guillon, A. ;

Andres, C. ;

Herault, O. ;

Le Pape, A. ;

Diot, P. ;

Lemarie, E. ;

Paintaud, G. ;

Gouilleux-Gruart, V. ;

Heuze-Vourc'h, N. .

JOURNAL OF CONTROLLED RELEASE, 2014, 196 :344-354

[7]

Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics [J].

Guillon, A. ;

Secher, T. ;

Dailey, L. A. ;

Vecellio, L. ;

de Monte, M. ;

Si-Tahar, M. ;

Diot, P. ;

Page, C. P. ;

Heuze-Vourc'h, N. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 536 (01) :116-126

[8]

Protein stability in pulmonary drug delivery via nebulization [J].

Hertel, Sebastian P. ;

Winter, Gerhard ;

Friess, Wolfgang .

ADVANCED DRUG DELIVERY REVIEWS, 2015, 93 :79-94

[9]

Delivery strategies for sustained drug release in the lungs [J].

Loira-Pastoriza, Cristina ;

Todoroff, Julie ;

Vanbever, Rita .

ADVANCED DRUG DELIVERY REVIEWS, 2014, 75 :81-91

[10]

Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments [J].

Pritchard, John N. ;

Hatley, Ross H. M. ;

Denyer, John ;

von Hollen, Dirk .

THERAPEUTIC DELIVERY, 2018, 9 (02) :121-136

← 1 2 →